Macrogen, Inc. is a leading South Korea-based biotechnology company specializing in genomic sequencing and precision medicine. 

Established in 1997 and listed on the KOSDAQ in 2000, Macrogen offers a wide range of services including whole genome sequencing (WGS), whole exome sequencing (WES), RNA sequencing, microbiome analysis, and clinical genetic testing. Equipped with advanced platforms such as Illumina NovaSeq, PacBio, and Oxford Nanopore, and backed by CAP and CLIA-certified laboratories, the company provides high-quality genomic solutions to researchers, hospitals, and pharmaceutical companies worldwide. 

With branches in the United States, Europe, and Japan, Macrogen supports clients in over 150 countries, making it a trusted global partner in genomics.